title: An engineered U1 small nuclear RNA rescues splicing defective coagulation F7 gene expression in mice.
abstract: The ability of the spliceosomal small nuclear RNA U1 (U1snRNA) to rescue pre-mRNA splicing impaired by mutations makes it an attractive therapeutic molecule. Coagulation factor deficiencies due to splicing mutations are relatively frequent and could therefore benefit from this strategy. However, the effects of U1snRNAs in vivo remain unknown.
  
  
  
  To assess the rescue of the F7 c.859+5G>A splicing mutation (FVII+5A), causing severe human factor VII (hFVII) deficiency, by the modified U1snRNA+5a (U1+5a) in a murine model.
  
  
  
  Mice expressing the human F7 c.859+5G>A mutant were generated following liver-directed expression by plasmid or recombinant adeno-associated viral (AAV) vector administration. The rescue of the splice-site defective pre-mRNA by U1+5a was monitored in liver and plasma through hFVII-specific assays.
  
  
  
  Injection of plasmids encoding the U1+5a rescued plasma hFVII levels, which increased from undetectable to ~8.5% of those obtained with the wild-type hFVII plasmid control. To assess long-term effects, mice were injected with low and high doses of two AAV vectors encoding the FVII+5A splice site mutant as template to be corrected by U1+5a. This strategy resulted in hFVII plasma levels of 3.9 ± 0.8 or 23.3 ± 5.1 ng mL⁻¹ in a dose-dependent manner, corresponding in patients to circulating FVII levels of ~1-4.5% of normal. Moreover, in both experimental models, we also detected correctly spliced hFVII transcripts and hFVII-positive cells in liver cells.
  
  
  
  Here we provide the first in vivo proof of-principle of the rescue of the expression of a splicing-defective F7 mutant by U1snRNAs, thus highlighting their therapeutic potential in coagulation disorders.
authors.forename: D
authors.initials: D
authors.lastname: Balestra
authors.forename: A
authors.initials: A
authors.lastname: Faella
authors.forename: P
authors.initials: P
authors.lastname: Margaritis
authors.forename: N
authors.initials: N
authors.lastname: Cavallari
authors.forename: F
authors.initials: F
authors.lastname: Pagani
authors.forename: F
authors.initials: F
authors.lastname: Bernardi
authors.forename: V R
authors.initials: VR
authors.lastname: Arruda
authors.forename: M
authors.initials: M
authors.lastname: Pinotti
mesh_terms: D000818:Animals; D001483:Base Sequence; D001778:Blood Coagulation Disorders / Q000235:genetics*; D017931:DNA Primers; D015870:Gene Expression / Q000235:genetics*; D005822:Genetic Vectors; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D012326:RNA Splicing; D012342:RNA, Small Nuclear / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D017931:DNA Primers; D012342:RNA, Small Nuclear; C405483:U1 small nuclear RNA
references.citation: Nat Med. 1999 Jan;5(1):56-63
references.pmid: 9883840
references.citation: Proc Natl Acad Sci U S A. 1987 Aug;84(15):5158-62
references.pmid: 3037537
references.citation: Mol Ther. 2011 May;19(5):936-41
references.pmid: 21326217
references.citation: Blood. 2008 Mar 1;111(5):2681-4
references.pmid: 18156490
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11854-9
references.pmid: 12192090
references.citation: J Thromb Haemost. 2011 Nov;9(11):2143-52
references.pmid: 21854538
references.citation: Hum Gene Ther. 1996 Mar 20;7(5):637-45
references.pmid: 8845389
references.citation: Am J Hum Genet. 2010 Oct 8;87(4):480-93
references.pmid: 20869034
references.citation: Mol Cell Biol. 2008 May;28(9):3070-5
references.pmid: 18316400
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3758-63
references.pmid: 16501048
references.citation: Hum Mutat. 2004 Sep;24(3):225-35
references.pmid: 15300850
references.citation: Genes Dev. 2003 Feb 15;17(4):419-37
references.pmid: 12600935
references.citation: Hum Mutat. 2011 Jul;32(7):815-24
references.pmid: 21520335
references.citation: Hum Mutat. 2009 Feb;30(2):255-63
references.pmid: 18837008
references.citation: J Med Genet. 2003 Mar;40(3):220-2
references.pmid: 12624144
references.citation: Blood. 1998 Sep 1;92(5):1646-51
references.pmid: 9716592
references.citation: Trends Genet. 1994 Mar;10(3):100-6
references.pmid: 8178363
references.citation: Hum Mol Genet. 2012 Jun 1;21(11):2389-98
references.pmid: 22362925
references.citation: J Thromb Haemost. 2009 May;7(5):774-9
references.pmid: 19245420
references.citation: Hum Genet. 1992 Sep-Oct;90(1-2):41-54
references.pmid: 1427786
references.citation: Hum Genet. 1993 Nov;92(5):446-50
references.pmid: 8244334
references.citation: Gene Ther. 1998 Jul;5(7):938-45
references.pmid: 9813665
references.citation: Haemophilia. 2010 Jul;16 Suppl 5:22-8
references.pmid: 20590852
references.citation: RNA Biol. 2010 Jul-Aug;7(4):430-40
references.pmid: 20523126
references.citation: Blood. 2009 Apr 16;113(16):3682-9
references.pmid: 19109232
references.citation: Nucleic Acids Res. 2007;35(13):4250-63
references.pmid: 17576681
references.citation: Hum Mutat. 2007 Feb;28(2):150-8
references.pmid: 17001642
references.citation: N Engl J Med. 2011 Dec 22;365(25):2357-65
references.pmid: 22149959
references.citation: Nature. 1997 Nov 20;390(6657):290-4
references.pmid: 9384381
references.citation: Nature. 2006 May 25;441(7092):537-41
references.pmid: 16724069
references.citation: Blood. 2009 Jun 18;113(25):6461-4
references.pmid: 19387004